Missouri Code of State Regulations › Title 20 - DEPARTMENT OF COMMERCE AND INSURANCE › Division 2220 - State Board of Pharmacy › Chapter 6 - Pharmaceutical Care Standards › Section 20 CSR 2220-6.060 - General Provisions

Current through Register Vol. 49, No. 14, July 15, 2024
PURPOSE: This rule establishes definitions for
				  20 CSR
				  2220-6.060 to
				  20 CSR
				  2220-6.080 governing medication therapy services by
				  pharmacists.
(1) Definitions.
				The following definitions shall apply for purposes of
				20 CSR
				2220-6.060 to
				20 CSR
				2220-6.080:
(A)
				Authorizing physician(s)-The physician identified in the written protocol as
				authorizing the pharmacist to provide medication therapy services;
(B) Health care entity-For purposes of this
				rule, a health care entity shall be defined as any entity or organization that
				is licensed or certified by the state or federal government as a hospital,
				hospice facility, ambulatory surgical center, nursing home, long-term care
				facility, residential care facility, assisted living facility, intermediate
				care facility, skilled nursing facility, or a habilitation center as defined by
				Chapter 630, RSMo, and that is required to maintain patient medical records by
				state or federal law;
(C)
				Medication therapy protocol-A written agreement between a physician and a
				pharmacist for the provision of medication therapy services. A medication
				therapy protocol shall comply with the provisions of
				20 CSR
				2220-6.080;
(D) Medication therapy services-The
				designing, initiating, implementing, or monitoring of a plan to monitor the
				medication therapy or device usage of a specific patient, or to enhance
				medication therapeutic outcomes of a specific patient, by a pharmacist who has
				authority to initiate or implement a modification of the patient's medication
				therapy or device usage pursuant to a medication therapy protocol. For purposes
				of
				20 CSR
				2220-6.060 to
				20 CSR
				2220-6.080, modification shall include selecting a
				new, different, or additional medication or device, discontinuing a current
				medication or device, or selecting a new, different, or additional strength,
				dose, dosage form, dosage schedule, or route of administration for a current
				medication or device, and implementing such selection(s). Medication therapy
				services shall not include the sole act of dispensing a drug or device pursuant
				to a valid prescription for the product, generic substitutions made pursuant to
				section
				338.056,
				RSMo, or medication therapy management that does not include the initiation or
				implementation of a modification of medication therapy, as provided
				herein;
(E) Pharmacy resident-A
				Missouri-licensed pharmacist enrolled in a residency training program
				accredited by the American Society of Health-System Pharmacists or a residency
				training program with a valid application for accreditation pending with the
				American Society of Health-System Pharmacists;
(F) Prescription order for medication
				therapeutic plan-A lawful order that is issued by the authorizing physician
				within the scope of his/her professional practice for the provision of
				medication therapy services by a pharmacist for a specific patient, including,
				patients of a health care entity; and
(G) Protocol-A medication therapy protocol,
				as defined herein.